Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 31 | 2022 | 445 | 4.560 |
Why?
|
| Lasers, Solid-State | 7 | 2025 | 23 | 3.500 |
Why?
|
| Lithotripsy, Laser | 6 | 2025 | 16 | 2.800 |
Why?
|
| Laser Therapy | 7 | 2022 | 241 | 2.260 |
Why?
|
| Lithotripsy | 3 | 2023 | 21 | 1.610 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2022 | 229 | 1.520 |
Why?
|
| Graphite | 3 | 2019 | 16 | 1.240 |
Why?
|
| Lasers | 9 | 2025 | 111 | 1.170 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 67 | 1.060 |
Why?
|
| Scattering, Radiation | 9 | 2018 | 50 | 0.960 |
Why?
|
| Lasers, Semiconductor | 1 | 2025 | 8 | 0.900 |
Why?
|
| Kidney Calculi | 1 | 2025 | 39 | 0.860 |
Why?
|
| Coronary Vessels | 8 | 2023 | 523 | 0.850 |
Why?
|
| Refractometry | 4 | 2015 | 9 | 0.800 |
Why?
|
| Port-Wine Stain | 2 | 2022 | 10 | 0.780 |
Why?
|
| Cartilage | 6 | 2006 | 52 | 0.780 |
Why?
|
| Algorithms | 12 | 2016 | 1661 | 0.750 |
Why?
|
| Phantoms, Imaging | 9 | 2025 | 141 | 0.720 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2016 | 150 | 0.720 |
Why?
|
| Calculi | 1 | 2021 | 12 | 0.710 |
Why?
|
| Optics and Photonics | 4 | 2019 | 105 | 0.660 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 1306 | 0.650 |
Why?
|
| Doxorubicin | 2 | 2019 | 290 | 0.610 |
Why?
|
| Microvessels | 2 | 2021 | 58 | 0.540 |
Why?
|
| Liposomes | 2 | 2019 | 197 | 0.530 |
Why?
|
| Birefringence | 6 | 2012 | 10 | 0.530 |
Why?
|
| Light | 12 | 2016 | 167 | 0.530 |
Why?
|
| Photochemotherapy | 1 | 2017 | 40 | 0.520 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 122 | 0.500 |
Why?
|
| Nanoparticles | 2 | 2018 | 298 | 0.500 |
Why?
|
| Retinal Ganglion Cells | 4 | 2014 | 97 | 0.480 |
Why?
|
| Thulium | 3 | 2025 | 12 | 0.470 |
Why?
|
| Models, Theoretical | 2 | 2015 | 358 | 0.460 |
Why?
|
| Optic Nerve | 3 | 2014 | 110 | 0.460 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 56 | 0.450 |
Why?
|
| Glioblastoma | 1 | 2019 | 372 | 0.440 |
Why?
|
| Nerve Fibers | 5 | 2014 | 65 | 0.430 |
Why?
|
| Hyperthermia, Induced | 3 | 2019 | 51 | 0.430 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 108 | 0.420 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2013 | 119 | 0.410 |
Why?
|
| Retinal Neurons | 1 | 2014 | 14 | 0.410 |
Why?
|
| Optic Disk | 3 | 2014 | 44 | 0.390 |
Why?
|
| Retina | 2 | 2013 | 423 | 0.390 |
Why?
|
| Holmium | 3 | 2022 | 10 | 0.390 |
Why?
|
| Hot Temperature | 6 | 2025 | 139 | 0.380 |
Why?
|
| Vascular Calcification | 2 | 2023 | 69 | 0.380 |
Why?
|
| Microscopy, Polarization | 2 | 2009 | 7 | 0.370 |
Why?
|
| Oximetry | 1 | 2013 | 176 | 0.360 |
Why?
|
| Image Enhancement | 3 | 2009 | 159 | 0.350 |
Why?
|
| Nephelometry and Turbidimetry | 2 | 2015 | 8 | 0.340 |
Why?
|
| Retinal Vessels | 1 | 2011 | 48 | 0.330 |
Why?
|
| Humans | 43 | 2025 | 130154 | 0.320 |
Why?
|
| Animals | 24 | 2022 | 33698 | 0.320 |
Why?
|
| Urinary Calculi | 2 | 2025 | 16 | 0.310 |
Why?
|
| Oxygen | 1 | 2013 | 549 | 0.300 |
Why?
|
| Models, Biological | 4 | 2017 | 1376 | 0.300 |
Why?
|
| Swine | 9 | 2022 | 1184 | 0.270 |
Why?
|
| Femoral Artery | 2 | 2019 | 134 | 0.270 |
Why?
|
| Tomography | 2 | 2004 | 32 | 0.260 |
Why?
|
| Cornea | 1 | 2011 | 565 | 0.250 |
Why?
|
| Renal Artery | 1 | 2006 | 71 | 0.240 |
Why?
|
| Connective Tissue | 1 | 2006 | 26 | 0.240 |
Why?
|
| Blood Vessels | 2 | 2022 | 92 | 0.230 |
Why?
|
| Equipment Design | 5 | 2015 | 510 | 0.230 |
Why?
|
| Computer Simulation | 4 | 2025 | 670 | 0.220 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2005 | 27 | 0.220 |
Why?
|
| Therapeutic Irrigation | 1 | 2025 | 44 | 0.220 |
Why?
|
| Low-Level Light Therapy | 1 | 2005 | 19 | 0.220 |
Why?
|
| Blood Flow Velocity | 2 | 2022 | 416 | 0.220 |
Why?
|
| In Vitro Techniques | 4 | 2015 | 806 | 0.220 |
Why?
|
| Phototherapy | 2 | 2019 | 37 | 0.210 |
Why?
|
| Peripheral Arterial Disease | 2 | 2019 | 324 | 0.210 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 2079 | 0.210 |
Why?
|
| Microscopy, Interference | 1 | 2004 | 5 | 0.210 |
Why?
|
| Fractures, Stress | 1 | 2023 | 14 | 0.200 |
Why?
|
| Fourier Analysis | 2 | 2015 | 54 | 0.200 |
Why?
|
| Cardiologists | 1 | 2023 | 25 | 0.200 |
Why?
|
| Neurofibroma | 1 | 2023 | 7 | 0.200 |
Why?
|
| Skin | 4 | 2008 | 539 | 0.190 |
Why?
|
| Interferometry | 1 | 2003 | 21 | 0.190 |
Why?
|
| Erbium | 1 | 2022 | 3 | 0.190 |
Why?
|
| Bacillus subtilis | 1 | 2022 | 41 | 0.190 |
Why?
|
| Neurofibromatosis 1 | 1 | 2023 | 70 | 0.190 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 2896 | 0.180 |
Why?
|
| Temperature | 3 | 2017 | 288 | 0.180 |
Why?
|
| Osteoarthritis | 1 | 2004 | 105 | 0.180 |
Why?
|
| Glaucoma | 2 | 2014 | 73 | 0.180 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 2015 | 13 | 0.180 |
Why?
|
| Hemostasis | 1 | 2022 | 76 | 0.180 |
Why?
|
| Optic Nerve Diseases | 2 | 2014 | 76 | 0.180 |
Why?
|
| Neointima | 3 | 2019 | 48 | 0.180 |
Why?
|
| Arteries | 1 | 2003 | 209 | 0.170 |
Why?
|
| Mice | 5 | 2022 | 18172 | 0.170 |
Why?
|
| Blood Coagulation | 1 | 2022 | 134 | 0.170 |
Why?
|
| Biopsy | 2 | 2022 | 1237 | 0.170 |
Why?
|
| Laser Coagulation | 1 | 2022 | 114 | 0.170 |
Why?
|
| Fluorescein Angiography | 1 | 2021 | 63 | 0.170 |
Why?
|
| HMGB1 Protein | 1 | 2021 | 30 | 0.170 |
Why?
|
| Macrophages | 2 | 2015 | 660 | 0.170 |
Why?
|
| Angiography | 1 | 2021 | 181 | 0.160 |
Why?
|
| Infrared Rays | 3 | 2017 | 19 | 0.160 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 79 | 0.160 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 358 | 0.160 |
Why?
|
| Biomedical Engineering | 1 | 2019 | 21 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 304 | 0.150 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 11 | 0.150 |
Why?
|
| Materials Testing | 2 | 2018 | 73 | 0.150 |
Why?
|
| Biotechnology | 1 | 2019 | 59 | 0.150 |
Why?
|
| Quantum Dots | 1 | 2019 | 16 | 0.150 |
Why?
|
| Vascular Patency | 1 | 2019 | 179 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2019 | 131 | 0.140 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 67 | 0.140 |
Why?
|
| Absorption, Physicochemical | 1 | 2018 | 3 | 0.140 |
Why?
|
| Radiometry | 4 | 2008 | 49 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 588 | 0.140 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 889 | 0.140 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 254 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2019 | 259 | 0.140 |
Why?
|
| Water | 2 | 2018 | 185 | 0.140 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 358 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 87 | 0.140 |
Why?
|
| Models, Cardiovascular | 3 | 2014 | 165 | 0.140 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 122 | 0.140 |
Why?
|
| Endovascular Procedures | 2 | 2018 | 779 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2019 | 361 | 0.140 |
Why?
|
| Particle Size | 1 | 2018 | 135 | 0.140 |
Why?
|
| Thermogravimetry | 1 | 2017 | 5 | 0.140 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2017 | 7 | 0.140 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 43 | 0.130 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2017 | 40 | 0.130 |
Why?
|
| Oxides | 1 | 2017 | 17 | 0.130 |
Why?
|
| Static Electricity | 1 | 2017 | 44 | 0.130 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 115 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 130 | 0.130 |
Why?
|
| Biological Availability | 1 | 2017 | 136 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4646 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2017 | 117 | 0.130 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 2289 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 408 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 2601 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2017 | 395 | 0.120 |
Why?
|
| Aspirin | 1 | 2018 | 213 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 708 | 0.120 |
Why?
|
| Macaca mulatta | 3 | 2012 | 492 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 268 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 903 | 0.120 |
Why?
|
| Angina, Stable | 1 | 2015 | 8 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 766 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 735 | 0.110 |
Why?
|
| Stents | 3 | 2018 | 785 | 0.110 |
Why?
|
| Aged | 8 | 2019 | 20833 | 0.110 |
Why?
|
| Metals | 1 | 2014 | 70 | 0.100 |
Why?
|
| Normal Distribution | 1 | 2014 | 19 | 0.100 |
Why?
|
| Artifacts | 1 | 2014 | 99 | 0.100 |
Why?
|
| Middle Aged | 9 | 2019 | 28331 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1910 | 0.100 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2004 | 23 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3714 | 0.100 |
Why?
|
| Oxyhemoglobins | 1 | 2013 | 25 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 2980 | 0.100 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2013 | 44 | 0.100 |
Why?
|
| Thrombosis | 1 | 2018 | 498 | 0.100 |
Why?
|
| Electric Stimulation | 2 | 2004 | 234 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 875 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 235 | 0.090 |
Why?
|
| Models, Statistical | 3 | 2004 | 484 | 0.090 |
Why?
|
| Time Factors | 6 | 2019 | 6178 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1481 | 0.090 |
Why?
|
| Scanning Laser Polarimetry | 1 | 2011 | 2 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2020 | 1440 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2023 | 943 | 0.080 |
Why?
|
| Axons | 1 | 2014 | 382 | 0.080 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 297 | 0.080 |
Why?
|
| Brain | 1 | 2022 | 3146 | 0.080 |
Why?
|
| Succinates | 1 | 2010 | 15 | 0.080 |
Why?
|
| Soot | 1 | 2010 | 14 | 0.080 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 30 | 0.080 |
Why?
|
| Rats | 2 | 2009 | 3378 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 744 | 0.080 |
Why?
|
| X-Ray Microtomography | 2 | 2023 | 101 | 0.080 |
Why?
|
| Calcium | 2 | 2023 | 1008 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2023 | 12843 | 0.070 |
Why?
|
| Female | 11 | 2019 | 70285 | 0.070 |
Why?
|
| Skin Temperature | 1 | 2007 | 17 | 0.070 |
Why?
|
| Gold | 1 | 2008 | 54 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2007 | 131 | 0.060 |
Why?
|
| United States | 2 | 2019 | 11885 | 0.060 |
Why?
|
| Elastin | 1 | 2006 | 32 | 0.060 |
Why?
|
| Male | 11 | 2019 | 64397 | 0.060 |
Why?
|
| Intervertebral Disc | 1 | 2006 | 13 | 0.060 |
Why?
|
| Tissue Survival | 1 | 2006 | 7 | 0.060 |
Why?
|
| Magnetics | 1 | 2006 | 32 | 0.060 |
Why?
|
| Anisotropy | 1 | 2006 | 117 | 0.060 |
Why?
|
| Rabbits | 2 | 2006 | 573 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 497 | 0.060 |
Why?
|
| Nasal Septum | 1 | 2006 | 27 | 0.060 |
Why?
|
| Cartilage Diseases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 185 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 279 | 0.050 |
Why?
|
| Tomography, Optical | 1 | 2004 | 7 | 0.050 |
Why?
|
| Rhinoplasty | 1 | 2006 | 56 | 0.050 |
Why?
|
| Contrast Media | 1 | 2008 | 473 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2019 | 623 | 0.050 |
Why?
|
| Freezing | 1 | 2004 | 27 | 0.050 |
Why?
|
| Fibrosis | 2 | 2016 | 419 | 0.050 |
Why?
|
| Hair | 1 | 2004 | 30 | 0.050 |
Why?
|
| Acoustics | 1 | 2004 | 20 | 0.050 |
Why?
|
| Software | 2 | 2006 | 733 | 0.050 |
Why?
|
| Cryosurgery | 1 | 2004 | 51 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 178 | 0.050 |
Why?
|
| Nanotechnology | 1 | 2003 | 49 | 0.050 |
Why?
|
| Intraocular Pressure | 2 | 2014 | 108 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 110 | 0.050 |
Why?
|
| Chorion | 1 | 2002 | 16 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2002 | 121 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 979 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2022 | 335 | 0.040 |
Why?
|
| Keratoconus | 1 | 2002 | 51 | 0.040 |
Why?
|
| Parathyroidectomy | 1 | 2021 | 51 | 0.040 |
Why?
|
| Calreticulin | 1 | 2021 | 23 | 0.040 |
Why?
|
| Corneal Topography | 1 | 2002 | 143 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2021 | 97 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2002 | 286 | 0.040 |
Why?
|
| Alloys | 1 | 2019 | 12 | 0.040 |
Why?
|
| Young Adult | 1 | 2014 | 9987 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2003 | 321 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2019 | 46 | 0.040 |
Why?
|
| Carbon | 1 | 2019 | 100 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4693 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3781 | 0.030 |
Why?
|
| Risk Factors | 2 | 2025 | 10953 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 40 | 0.030 |
Why?
|
| Walk Test | 1 | 2018 | 25 | 0.030 |
Why?
|
| Adult | 3 | 2014 | 31042 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 6403 | 0.030 |
Why?
|
| Europe | 1 | 2018 | 360 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 151 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 123 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 164 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 115 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 699 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 446 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6768 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2015 | 49 | 0.030 |
Why?
|
| Blood Physiological Phenomena | 1 | 2014 | 5 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 205 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1166 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 563 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 2014 | 17 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 684 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 303 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 191 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 83 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2014 | 449 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2010 | 32 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2887 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 929 | 0.020 |
Why?
|
| Solvents | 1 | 2010 | 41 | 0.020 |
Why?
|
| Photography | 1 | 2008 | 79 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1610 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2007 | 28 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 214 | 0.020 |
Why?
|
| Time | 1 | 2006 | 92 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2006 | 48 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 2193 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 4848 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 814 | 0.010 |
Why?
|
| Thermography | 1 | 2004 | 12 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 361 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2004 | 81 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2003 | 39 | 0.010 |
Why?
|
| Biophysics | 1 | 2003 | 47 | 0.010 |
Why?
|
| Methacrylates | 1 | 2002 | 15 | 0.010 |
Why?
|
| Contact Lenses | 1 | 2002 | 39 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 450 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 832 | 0.010 |
Why?
|